From the Laboratory to the Clinic 2026: Complex pathogenesis of disease

Established in 1984, From the Laboratory to the Clinic is a deliberately translational meeting for basic scientists, clinicians and industry researchers who want to connect mechanisms of disease with therapeutic development. The 2026 programme is organised around immunology and metabolism, microbial effects on disease, tissue repair, metabolism and two neurodegeneration sessions. Confirmed contributors span GLP-1 biology, immunometabolism, the microbiome, neural stem-cell translation, autophagy and antibody–Fc receptor biology, giving the conference unusually broad value across inflammatory, metabolic and neurological disease.

The meeting runs from lunch on Tuesday to lunch on Friday in Trinity College’s Levine Building Auditorium, with live online streaming for people who cannot attend Oxford. Its in-person format includes refreshment-area posters throughout the meeting and a Wednesday dinner at the Oxford University Museum of Natural History. Poster applicants provide a title and a 100-word abstract during registration; successful applicants are due to be notified on 7 August and must prepare a portrait A1 or A0 poster.

This is best suited to research-active clinicians, clinical academics and doctors interested in translational medicine rather than a guideline-led clinical update. The organiser summary says registration is closed while the attendee form remains reachable, so availability should be checked directly before making travel plans.